Jeannie Wall

Jeannie Wall has a diverse work experience in the healthcare and clinical research industry. Jeannie has held various roles in different companies, primarily in the field of clinical research. Their most recent position was as an Associate Director of Clinical Quality Assurance at Geron Corporation, starting in June 2023. Prior to that, they worked as a Risk Management Associate Lead at Janssen Inc. from July 2022 to June 2023. Jeannie also held the position of Senior Site Manager at The Janssen Pharmaceutical Companies of Johnson & Johnson from August 2017 to August 2022. Before that, they worked as a Clinical Research Associate and In-House Clinical Research Associate at PRA Health Sciences, focusing on the Janssen ED&CP project. Jeannie's previous experience includes roles such as Co-operative Education and Intern Recruiter and Trainer at CRI Lifetree, Site Management Assistant at Covance, and various positions at CRI Lifetree (formerly CRI Worldwide). Jeannie also had a brief experience as a Senior Caregiver and Home Health Aide at Home Helpers of Southeast Pennsylvania. Overall, Jeannie Wall has a strong background in clinical research and a demonstrated track record in various roles within the healthcare industry.

Jeannie Wall, DHSc/PhD, MHSc, has an extensive education history in the field of health sciences. Jeannie initially earned their Bachelor of Health Sciences degree from Drexel University in the period of 2007 to 2011. Subsequently, they pursued a Master of Health Sciences degree in Health Science/ Clinical Research at Saint Francis University from 2012 to 2014. Jeannie then furthered their education by completing a Doctor of Health Science degree with a focus on Global Health at Nova Southeastern University from 2014 to 2018. Additionally, they obtained a Registered Nursing/Registered Nurse qualification from Bucks County Community College. Most recently, they earned a Master of Science degree in Educational Leadership and Administration, which was conferred by Nova Southeastern University from 2018 to 2021.